Bacteria associated with the development of celiac disease
Commensal bacteria (normal constituents of the intestinal flora) play a crucial role in the development and maintenance of immune system balance in the gut.
UC: Current therapies
Once-daily dosing of mesalamine is sufficient for maintenance of remission in patients with ulcerative colitis (UC)
The P13 kinase pathway
A novel therapeutic target in the treatment of IBD and colorectal cancer?
Can predict clinical remission in patients with early-stage Crohn's disease
New susceptibility loci in IBD
The search for susceptibility loci for chronique inflammatory bowel diseases (IBD) over the last 20 years has led to identification of a number of genetic factors implicated in the pathogenesis of these diseases.
Genetic signatures: new clinical tools?
Mucosal genetic signatures for predicting the response to infliximab in patients with ulcerative colitis.
UC: three new genetic susceptibility factors
Three new studies on the search for genetic susceptibility factors for IBD